"Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

Trelagliptin

Trelagliptin tablets

Trial Locations (1)

Takeda Selected Site, Tokyo